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Background: Chronic ﬂuid overload is frequent in hemodialysis patients (P) and it asso-
ciates with hypertension, left ventricular hypertrophy (LVH) and higher mortality. Moreover,
echocardiographic data assessing ﬂuid overload is limited. Our aim was to evaluate the rela-
tionship between ﬂuid overload measured by bioimpedance spectroscopy (BIS) and different
echocardiographic parameters.
Methods: Cross-sectional observational study including 76 stable patients. Dry weight was
clinically assessed. BIS and echocardiography were performed. Weekly time-averaged ﬂuid
overload (TAFO) and relative ﬂuid overload (FO/ECW) were calculated using BIS measure-
ments.
Results: Based on TAFO three groups were deﬁned: A- dehydrated, TAFO <-0.25 L 32 P (42%);
B-  normohydrated, TAFO between -0.25 and 1.5 l: 26 (34%); C- overhydrated, TAFO>1.5 l: 18
(24%).  We  found signiﬁcant correlation between TAFO and left atrial volume index (LAVI) (r:
0.29; p=0.013) but not with FO/ECW (r 0.06; p=0.61). TAFO, but not FO/ECW kept a signiﬁcant
relationship with LAVI (p=0.03) using One-Way ANOVA test and linear regression methods.
LVH  was present in 73.7% (concentric 63.2%, eccentric in 10.5%). No differences between
groups in the presence of LVH or left ventricular mass index were found.
Conclusions: We  found that left atrial volume index determined by echocardiographic Area-
length method, but not left ventricle hypertrophy or dimensions of cavities, are related on
hydration status based on bioimpedance measured time-averaged ﬂuid overload (TAFO),
and not with FO/ECW.
© 2016 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an
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Hallazgos  ecocardiográﬁcos  en  pacientes  en  hemodiálisis  según  su
estado  de  hidratación
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r  e  s  u  m  e  n
Introducción: La sobrehidratación es frecuente en pacientes en hemodiálisis (P) y se aso-
cia con hipertensión, hipertroﬁa ventricular izquierda (LVH) y mayor mortalidad. Los datos
ecocardiográﬁcos evaluando sobrecarga hídrica son escasos. Nuestro objetivo fue evaluar la
relación entre sobrehidratación medida por Bioimpedancia multifrecuencia (BIS) y parámet-
ros  ecocardiográﬁcos.
Métodos: Estudio transversal observacional, con 76 P estables; El peso seco fue determi-
nado  clínicamente; se realizaron ecocardiograma, BIS y analítica sanguínea. Se calcularon
la  sobrehidratación promedio semanal (TAFO) y sobrehidratación relativa (FO/ECW).
Resultados: 3 grupos: A- deshidratados, TAFO <-0.25 L: 32 P (42,1%); B- normohidratado, TAFO
-0.25  - 1.5 L: 26 P (34,2%); C- sobrehidratados TAFO > 1.5 L: 18 P (23,7%). Encontramos cor-
relación signiﬁcativa entre TAFO e índice de volumen auricular izquierdo (LVAI) (r: 0.29;
p=0.013) y no con FO/ECW (rho 0,06; p = 0,61). TAFO, pero no FO/ ECW, mantuvo una relación
signiﬁcativa con LVAI (p = 0,03) utilizando test de ANOVA y regresión lineal. LVH estuvo
presente en 73,7% de P (concéntrica 63,2%, excéntrica 10,5%). No encontramos diferencias
entre grupos en cuanto a la presencia de LVH, ni del índice de masa ventricular izquierda.
Conclusiones: Nosotros observamos que el índice de volumen auricular izquierdo deter-
minado por longitud de área medida por ecocardiograma y no la hipertroﬁa ventricular
izquierda o dimensión de cavidades se relaciona con el estado de hidratación medido por
sobrehidatación semanal y no con FO/ECW.
© 2016 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/Introduction
Chronic ﬂuid overload is a frequent problem in patients
treated by hemodialysis; and it is known to be associ-
ated with different clinical conditions like hypertension,
increased arterial stiffness, left ventricular hypertrophy, heart
failure and consequently higher morbidity and mortality.1
In this regard, maintaining a normal extracellular volume
status2 is one of the major targets of the therapy; yet estab-
lishing the hydration state of dialysis patients is one of
the most challenging that nephrologists face in their daily
practice.
Hydration state can be measured by different meth-
ods. In clinical routine, ﬂuid management is largely based
on subjective clinical assessment and the probing for dry
weight procedure.3 New noninvasive bedside tools, such as
bioimpedance spectroscopy (BIS), facilitate objective assess-
ment of ﬂuid status.
Multifrequency bioimpedance spectroscopy is a vali-
dated technique that objectively deﬁnes the individual
overhydration status, taking into account the individual’s
body composition.4 The hydration status, evaluated by
bioimpedance spectroscopy, is an important and independent
predictor of mortality in chronic hemodialysis patients.5,6
Bioimpedance can be useful in guiding ﬂuid management with
a favorable impact in cardiovascular parameters.7 Fluid sta-
tus can be expressed as pre- or postdialytic ﬂuid overload,Please cite this article in press as: Cristina Di Gioia M, et al. Echocardiogr
hydration. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.06.003
but to assess the cardiovascular condition of a patient, the
time averaged ﬂuid overload (TAFO) seems to better reﬂect the
long-term cardiovascular load.8by-nc-nd/4.0/).
Cardiovascular disease is the major cause of death in
patients with advanced chronic disease9 and echocardiog-
raphy is an established technique to estimate the risk for
cardiovascular complications in patients with end-stage renal;
been a radiation free technique that provides noninvasive
assessment of cardiac structures and function. It is widely
available and recommended in patients with end-stage renal
disease for diagnosis, guidance of treatment, and pretrans-
plantation evaluation.10 However, there is limited data on
echocardiographic parameters evaluating hydration status in
patients undergoing dialysis.
Our aim was to assess the relationship between hydra-
tion status and echocardiographic parameters in hemodialysis
patients.
Methods
Patients
We conducted a cross-sectional study including 76 patients
(68.4% male) from the dialysis unit of a secondary hospital
with 103 hemodialysis patients. Patients that were more  than
two months in the technique in stable condition and with-
out hospital admissions during the previous two months were
included. Patients with contraindication for BIS (implanted
electronic device, metallic prostheses of any type, amputated
patients, pregnant or lactating women) were excluded. Sixaphic ﬁndings in haemodialysis patients according to their state of
patients (7.3%) with a previously known severe valvulopathy
or bad acoustic window also were excluded. Patients were
18 years old or above and had signed an informed consent
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pproved by the Institutional Ethics Committee of Severo
choa Hospital.
Blood samples for standard laboratory parameters and BIS
ere obtained in the same day, before the second dialysis
reatment of the week and after 20 min  in semi-recumbent
osition. Patients underwent echocardiography on the day fol-
owing midweek dialysis.
Demographic and clinical characteristics were recorded.
ry weight was determined by the patient’s attending physi-
ian in each hemodialysis session without knowledge of the
ioimpedance results. Under these conditions bioimpedance
as performed and weekly TAFO measured. Pre- and post-
ialysis body weight and blood pressure were collected.
ntradialytic symptoms were noted and classiﬁed as hypoten-
ion, cramps, or other. Hypertension was deﬁned as blood
ressure greater than 140–90 and or antihypertensive therapy.
nterdialytic weight gain and ultraﬁltration rates in mL/h/kg
ere recorded.
ioimpedance  assessment
ioimpedance was assessed using a Body Composition Mon-
tor (Fresenius Medical Care, Deutschland GmbH). Patients
ere measured before dialysis in a semirecumbent position
n their dialysis chair. Following measures were taken: Fluid
verload (FO), extracellular water (ECW), intracellular water
ICW) in liters, ECW/ICW ratio, lean tissue mass in percent-
ge (LTM %), lean tissue index (LTI) deﬁned as the quotient
f LTM/height2 (kg/m2), fat mass in percentage (FAT %),  fat
issue index (FTI) deﬁned as the quotient of FAT/height2
kg/m2) and phase angle (PA) in grades. Phase angle is cal-
ulated as the arctangent of reactance over resistance at
requency 50 kHz and is related to body cell mass and to the
istribution of ﬂuid between intracellular and extracellular
ompartments.11
Relative ﬂuid overload (FO/ECW) and TAFO were calculated.
or calculating TAFO, FO was additionally estimated for each
f the other two treatment days of the week by using differ-
nces in predialysis body weight (preweight) according to next
quation:
O estimation = FO BIS day + preweight estimation day
− preweight BIS day.
FO BIS day indicates real measurements. This approach
ssumes that treatment-to-treatment changes in preweight
ver a few days reﬂect mainly changes in FO and that body
omposition remains stable within this short time period.
ostdialysis FO was calculated by subtracting ultraﬁltration
olume from the predialysis measurement.
eﬁnition  of  time  averaged  ﬂuid  overload  (TAFO)
luid status in patients on intermittent ultraﬁltration ther-Please cite this article in press as: Cristina Di Gioia M, et al. Echocardiogr
hydration. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.06.003
py is time-dependent, being lowest just after dialysis and
eaching a maximum before the next dialysis session. In
ddition, ﬂuid status is usually higher after the long interdia-
ytic interval. To make different measurements of ﬂuid status x(x x):xxx–xxx 3
during the week comparable, the concept of weekly TAFO was
introduced. It represents the average cardiovascular ﬂuid load
over one complete week, assuming linear ﬂuid accumulation
in the interdialytic period. It is deﬁned as the average between
all three FO predialysis and postdialysis FO (FOpost) values of
the week.
Average weekly TAFO: (FO pre1 + FO pre2 + FO
pre3 + FOpost1 + FOpost2 + FOpost3)/6.12
In other studies, different TAFO values have been used to
determined hydration status among patients.8,12 In this study,
patients were divided into 3 groups based on time-averaged
ﬂuid overload: Group A (dehydrated), with TAFO <−0.25 L;
Group B (normohydrated), with TAFO between −0.25 and 1.5 L;
Group C (overhydrated), with TAFO >1.5 L.
Echocardiography
2D, M-mode and Doppler echocardiography was performed
on patients lying in the left decubitus position at base-
line, on the day after dialysis, by an experienced group of
sonographers from the echocardiography laboratory, using a
General Electric Vivid7 echocardiographic system with a 5S
transthoracic probe. Registries were reviewed by a single sono-
grapher, and all of them were blinded to the clinical details of
patients. All echocardiographic data were measured accord-
ing to the guidelines of the European and American Societies
of Echocardiography.13,14 Left ventricle (LV) mass was calcu-
lated using Devereux formula and indexing by body surface
area. Left atrial dilation was considered for a LAV >34 ml/m2.
Diastolic function measurements were assessed14 from the
apical view using transmitral power-Doppler. Right ventricle
diameter and function15 were determined from apical view
measuring subvalvular diameter, tricuspid annular plane sys-
tolic excursion (TAPSE) and tricuspid annulus systolic velocity
by tissue-Doppler.
Statistical  analysis
Data were processed with IBM SPSS19 program. Quantitative
data are expressed by mean (median for time variables) and a
conﬁdence interval of 95%, and qualitative variables by the
number of subjects (n) and its relative percentage. Groups
were deﬁned from time-averaged ﬂuid overload (TAFO) and
the OH/ECW ratio, and were compared by one-way ANOVA and
linear multivariate regression analysis (quantitave variables),
and Chi-square for trend (qualitative variables). A variation
>10% was settled for confounding factors. Correlations were
compared by Spearman’s rho. Statistically signiﬁcance was
considered when p < 0.05.
Results
Study  participants
Among the 76 patients included the median age was 63.1 (CIaphic ﬁndings in haemodialysis patients according to their state of
95% 60.0–66.2) years, men  52 P (68.4%) with a median dialy-
sis vintage of 36 (13.5–84) months. 31 patients (40, 8%) were
diabetics, 23 patients (30.3%) were hypertensive. The under-
lying renal disease was Diabetes 21 P; Vascular disease 17P;
ARTICLE IN PRESSNEFRO-238; No. of Pages 7
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Cystic hereditary disease 3P; Glomerulopathy 14P; interstitial
7 P; Unknown 12 P; Others 2 P. Regarding dialysis technique,
55 P (72.4%) patients were in conventional hemodialysis and
21 (27.6%) patients were in on-line hemodiaﬁltration. The vas-
cular access used was native arteriovenous ﬁstula in 40 (52%)
patients, Graft in 8 (10, 5%) patients and permanent central
catheter in 28 (37%) patients.
Overhydration  status  according  TAFO  measurements
Based on time-averaged ﬂuid overload 32 (42%) patients
were considered dehydrated; 26 (34%) patients were consid-
ered normohydrated and 18 (24%) patients were considered
overhydrated. Table 1 summarizes general characteristics
according TAFO groups. We found no differences between
groups regarding age, systolic and diastolic blood pressure,
diabetic history and dialysis vintage; regarding sex, men  more
often out of range (dehydrated or overhydrated). Addition-
ally, no differences were found with the dialysis technique,
the frequency of intradialysis hypotension and ultraﬁltration
rates. Interestingly, we founded that interdialytic weight gain
was higher in dehydrated and overhydrated patients com-
pared to normohydrated patients. As expected, in dehydrated
group, ECW/ICW index was lower and phase angle was higher.
While there was no difference of lean mass and fat mass
percentage, LTI was higher in dehydrated patients. In regardPlease cite this article in press as: Cristina Di Gioia M, et al. Echocardiogr
hydration. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.06.003
of biochemical parameters, there was no difference between
groups in serum sodium and creatinine; however, as usual,
albumin and hemoglobin levels were lower in overhydrated
patients.
Table 1 – Comparison of the whole population and the subgrou
All patients
n: 76
Dehydrated
n  = 32
Age (years) 63.1 (60.0–66.2) 60.1 (54.4–65
Sex (men) 52 (68%) 23 (71.9%) 
Dialysis vintage (months) 36 (13.5–84) 32 (19.5–10
Diabetes 31 (40.8%) 9 (29%) 
Hypertension 23 (30.3%) 7 (21%) 
TAFO (L/week) 0.07 (−0.22 to 0.37) −1.15 (−1.43 to
FO/ECW 0.07 (0.05–0.09) 0.01 (−0.01–0
SBP (mmHg) 139 (134–144) 133 (126 –14
DBP (mmHg) 72 (69–75) 73 (68–77) 
Ultraﬁltration rates (mL/h/kg) 8.0 (7.2–8.9) 8.2 (6.9–9.4)
Intradialysis hypotension 11 (14.5%) 4 (12.5%) 
Natremia (mEq/L) 137.0 (136.3–137.7) 136.8 (135.7–1
Creatinine (mg/dL) 8.0 (7.5–8.5) 8.6 (7.7–9.5)
Albumin (g/dL) 3.9 (3.8–3.9) 3.9 (3.8–4.0)
Hb (g/dL) 11.8 (11.5–12.0) 12.1 (11.7–12
ECW (L) 15.7 (15.0–16.3) 15.7 (14.7–16
ICW (L) 16.2 (15.4–17.0) 17.3 (16.0–18
ECW/ICW 0.97 (0.95–1.00) 0.91(0.88–0.9
LTI (kg/m2) 11.5 (10.9–12.0) 12.0 (11.1–13
LTM % 44.5 (41.6–47.3) 43.9 (39.5–48
FTI (kg/m2) 14.2 (13.1–15.3) 15.7 (13.9–17
FAT % 38.8 (36.7–40.9) 40.5 (37.2–43
Phase angle (◦) 4.46 (4.23–4.70) 5.09 (4.74–5.4
Mean and CI 95% are expressed for quantitative variables. N and (%) is gi
ﬂuid overload; SBP, systolic blood pressure; DBP, dyastolic blood pressure; H
lean tissue index; LTM %, percentage lean tissue mass; FTI, fat tissue inde x x(x x):xxx–xxx
Echocardiographic  results
Table 2 shows data about echocardiographic parameters. Left
atrial dilatation (LAVI >34 ml/m2) was present in 24 (33.3%)
patients without atrial ﬁbrillation, being moderate in 3 (4.2%)
and severe in 8 (18.1%). We  found a signiﬁcant correlation
between the hydration status measured by TAFO and left atrial
volume index (LAVI) (Spearman’s rho 0.29; p = 0.013). Interest-
ingly, this correlation was not found when the hydration status
was deﬁned by FO/ECW (Spearman’s rho 0.06; p = 0.61), in spite
of the signiﬁcant internal correlation between both measure-
ments (TAFO and FO/ECW) (Spearman’s rho 0, 46; p < 0.0001).
Three patients with atrial ﬁbrillation (3.9%, one from Group A
and 2 from Group C) were excluded of the analysis.
Using One-Way ANOVA test and linear regression meth-
ods, the TAFO deﬁned hydration status, but not the FO/ECW,
kept a signiﬁcant relationship with LAVI (p = 0.03). When
including age, sex, ethiology, dialysis vintage, comorbidities,
dialysis technique, hypertension, biochemical parameters
(Hemoglobin, Na, K, Albumin, Creatinin), and all echocardiog-
raphic measurements including valvular regurgitation and left
ventricle mass index, the only confounding factors identiﬁed
were lean and fat mass percentages related to total weight,
and diastolic function measured by transmitral velocities
ratio, but the adjusted relationship kept signiﬁcant (p = 0.036).
Plasma sodium was not different between the 37 patients
with (136.6 mEq/l; CI 95% 135.8–137.4) and 35 patients withoutaphic ﬁndings in haemodialysis patients according to their state of
(137.3 mEq/l; IC95% 136.1–138.6) atrial dilatation (p = 0.314).
Left ventricle hypertrophy was present in 73.7% of patients
and concentric remodeling in 7.9%. Concentric hypertrophy
ps stratiﬁed according TAFO level.
Normohydrated
n  = 26
Overhydrated
n  = 18
p
.9) 66.2 (61.3–71.0) 64.2 (59.5–68.8) 0.222
13 (50.1%) 16 (88.9%) 0.021
5) 37.5 (12–74) 45 (7.5–94.25) 0.818
12 (38.7%) 10 (32.3%) 0.131
11 (42%) 5 (27%) 0.234
 −0.87) 0.38 (0.22–0.54) 1.82 (1.60–2.03) <0.001
.03) 0.10 (0.08–0.12) 0.15 (0.13–0.17) <0.001
0) 144 (134 –155) 140 (129 –151) 0.155
71 (64–78) 72 (66–77) 0.898
 8.7 (7.5–9.9) 6.8 (5.2–8.3) 0.156
3 (11.5%) 4 (22.2%) 0.561
38.0) 137.5 (136.2–138.7) 136.9 (135.6–138.2) 0.713
 7.3 (6.5–8.1) 8.1 (7.3–9.0) 0.075
 3.9 (3.8–4.1) 3.7 (3.4–3.9) 0.011
.5) 11.8 (11.4–12.3) 11.2 (10.6–11.7) 0.018
.6) 14.3 (13.4–15.2) 17.7 (16.2–19.1) <0.001
. 7) 14.2 (13.1–15.3) 17.2 (15.8 –18.8) 0.001
5) 1.01(0.97–1.05) 1.03 (0.97–1.09) <0.001
.0) 10.5 (9.7–11.3) 11.8 (10.7–12.9) 0.036
.3) 42.8 (38.1–47.6) 47.8 (41.1–54.5) 0.403
.4) 13.7 (12.0– 15.4) 12.5(10.0–14.9) 0.056
.7) 39.3 (35.8–42.8) 35.0 (30.1–39.8) 0.403
4) 3.98 (3.63–4.32) 4.05 (3.65–4.46) <0.001
ven for qualitative variables. TAFO, time average ﬂuid overload; FO,
B, hemoglobin; ECW, extracelular water; ICW, intracelular water; LTI,
x; FAT %, percentage fat mass.
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Table 2 – Echocardiographic measurements.
Dehydratation Normohydratation Overhydratation p
LA indexed volume (ml/m2) 27.0 (23.0–30.9) 33.7 (29.1–38.4) 36.3 (27.3–45.3) 0.036a
LV mass index (g/m2) 136.8 (119.3–154.3) 123.4 (110.2–136.5) 142.6 (122.1–163.1) 0.290
LVED diameter (mm) 49.8 (46.9–52.7) 43.7 (41.5–46) 50.1 (48.0–52.1) 0.001
LVED diameter index (mm/m2) 27.7 (25.9–29.4) 26.7 (25.2–28.2) 27.8 (26.5–28.3) 0.576
IVS thickness (mm) 12.5 (11.8–13.4) 13 (12.0–14.0) 13.2 (11.9–14.6) 0.601
RVED diameter (mm) 32.8 (30.8–34.8) 30.7 (28.9–32.5) 35.3 (33.1–37.5) 0.001
RVED diameter index (mm/m2) 18.2 (17.2–19.2) 18.9 (17.4–20.3) 19.7 (18.5–20.9) 0.229
RA area (cm2) 13.9  (12.7–15.0) 13.1 (11.9–14.3) 15.2 (13.8–16.5) 0.102
Mitral E/A velocities ratio 0.8  (0.7–0.9) 0.8 (0.7–0.9) 0.8 (0.6–1.1) 0.823
Mitral annulus averaged Ea/Aa ratio 0.8  (0.7–1.0) 0.7 (0.6–0.8) 0.8 (0.6–1.0) 0.401
E/Ea ratio 10.7 (7.9–13.5) 11.5 (9.8–13.2) 12.3 (10–14.7) 0.670
Mitral annulus averaged Sa velocity (cm/s) 7.4 (6.5–8.2) 7.1 (6.2–7.9) 7.1 (5.9–8.3) 0.890
Peak Aortic velocity (m/s) 1.5 (1.3–1.7) 1.5 (1.4–1.7) 1.8 (1.5–2.11) 0.197
TAPSE (mm) 21.1  (19.8–22.4) 20.6 (18.8–22.3) 20.8 (18.9–22.7) 0.872
LV ejection fraction (%) 73.7 (69.8–7.7) 76.0 (72.1–79.9) 76.0 (70.9–81.0) 0.642
PSP (mmHg) 14.0 (11.1–6.9) 18.3 (12.6–23.9) 19.1 (13.9–24.4) 0.139
Moderate MR 4 (12.9%) 1 (3.8%) 2 (12.5%) 0.282
Moderate AR 0 (0%) 1 (3.8%) 1 (6.3%) 0.186
Mild pericardial effusion 3 (9.4%) 0 (0%) 1 (5.6%) 0.282
LV hypertrophy 25 (78.1%) 18 (72.0%) 13 (72.2%) 0.838
Concentric remodeling 2 (6.3%) 2 (8.0%) 2 (11.1%) 0.831
Concentric hypertrophy 19 (59.4%) 17 (68.0%) 12 (66.7%) 0.769
Eccentric hypertrophy 6 (18.8%) 1 (4.0%) 1 (5.6%) 0.146
Mean and CI 95% are expressed for quantitative variables. N and (%) is given for qualitative variables.
a Adjusted for mitral E/A ratio, percentage lean tissue mass and fat mass percentage.
LA, left atrium; LV, left ventricle; LVED, left ventricle end-diastolic: RVED, right ventricle end-diastolic; IVS, interventricular septum; IVC,
inferior vena cava; RA, right atrium: TAPSE, tricuspid annular plane systolic; PSP, pulmonary systolic pressure; MR, mitral regurgitation; AR,
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iaortic regurgitation.
as present in 63.2% of patients and eccentric hypertro-
hy only in 10.5%. No statistical difference between TAFO
eﬁned groups (p = 0.838) nor regarding left ventricle mass
ndex (p = 0.29) was found. Left ventricle ejection fraction
LVEF) was normal (in fact, all groups tended to hypercon-
ractility), but in two cases from group A (LVEF 36.47 and
5.2%, moderate and mild systolic dysfunction respectively)
nd one from group C (LVEF 46.7%, mild systolic dysfunc-
ion). 48 patients (66.7%) had a pattern of diastolic dysfunction
ype I, deﬁned by tissue-Doppler study of mitral annulus
nd power Doppler transmitral velocities, with no difference
etween groups (p = 0.401). There was no signiﬁcant difference
n the prevalence of interdialysis hypertension (Group A 21.9%,
roup B: 42.3%, Group C: 27.8% (p = 0.241)).
No severe valvulopathy was found: Moderate mitral regur-
itation was present in 9.2% of patients and moderate aortic
egurgitation in 2.6%, without differences between groups.
ild pericardial effusion was present in only 5.3% with no
igniﬁcant difference between groups. No pulmonary hyper-
ension was present, although pulmonary systolic pressure
ould only be determined in 40.8% of patients.
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n our patients from a single haemodialysis center, we  found
hat LAVI determined by echocardiographic Simpson’s rule,
ut not left ventricle hypertrophy or dimensions of cavities,
s related to hydration status based on TAFO, and does not onFO/ECW. Both parameters are determined by bioimpedance,
the latter having shown to be a predictor for mortality.5,16,6
Several reports on bioimpedance-guided ﬂuid management
have shown improvement in blood pressure control and other
cardiovascular parameters5,6 but still are under debate the
most appropriate target for volume management. In this study
we found a signiﬁcant correlation between the hydration sta-
tus measured by TAFO and left atrial volume index. It has been
hypothesized that weekly TAFO could be an adequate measure
of cardiovascular overload.7,12
Left atrial volume (LAV) is more  accurate and is superior to
diameter and area for predicting cardiovascular outcomes.17
In dialysis patients, left atrium enlarges in response to an
increased preload (volume overload, arteriovenous ﬁstula,
mitral valve regurgitation, chronic anemia) or afterload (left
ventricular systolic dysfunction, valve stenosis, hypertension,
and left ventricle hypertrophy).10 In our study, there was no
difference between groups regarding these factors with the
exception of hydration status. Atrial ﬁbrillation promotes and
is maintained by atrial enlargement, and so we  excluded the
patients with atrial ﬁbrillation from atrial volume data. Some
authors18 have proposed to index LAV to height instead of
body surface area (BSA) in order to avoid possible ﬂuctuations
in body ﬂuid, muscle or fat affecting BSA in haemodialysis
patients, but we did not ﬁnd different results when doingaphic ﬁndings in haemodialysis patients according to their state of
so, perhaps because of using a more  steady parameter as
TAFO instead of FO/ECW, and a similar interdialysis weight
gain (about 2.6 kg) in dehydrated and overhydrated patients,
so that we used the more  stablished indexation to BSA. The
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same reﬂection applies to left ventricle mass index (LVMI)
where indexing to height2,7 could detect more  patients with
left ventricle hypertrophy and have a more  powerful progno-
stic impact.19
Left atrial volume predicts mortality and cardiovascular
events in patients undergoing hemodialysis20–22 indepen-
dently from left ventricle hypertrophy or function. Tripepi
et al.18 demonstrated that an increase in LAV by 1 ml/m2.7
per years independently predicts cardiovascular events. LAV
is a strong nonspeciﬁc indicator of cardiovascular pathology
and an ideal simple marker of diastolic dysfunction in every-
day clinical practice, and two dimensional echocardiography
is more  readily accessible than 3D echocardiography or cardiac
magnetic resonance.
Some data suggest a link between atrial enlargement and
plasma sodium,23,24 but we did not ﬁnd differences in plasma
sodium between groups (p = 0.713) or between patients with or
without atrial dilatation (p = 0.314).
Diastolic disfunction, measured by transmitral and tissue
Doppler, was present in the three groups with no relevant dif-
ference between them, and considered for adjustment in the
statistical analysis. Diastolic dysfunction is multifactorial and
almost universal in these patients, and volume is not its only
determinant.
Left ventricle hypertrophy was present in 73.7% of patients,
similar to previously reported data.25,26 In patients undergo-
ing dialysis, concentric hypertrophy, due to pressure overload
(mainly hypertension) together with stimulating factors as
mineral and bone disorder, renin-angiotensin system acti-
vation and endothelin,27,28 is more  prevalent than eccentric
hypertrophy. Many  formulas exist for calculating left ventri-
cular mass, been the Devereux formula commonly used and
validated. Limitations due to endocardial borders delineation
and the angle of probe during examination exist, and could
have affected our results too. Cardiac magnetic resonance or
3D echocardiography are more  accurate10,29,30 but less avail-
able for routine practice. LVH is predictive of mortality and
cardiovascular events in dialysis patients.31,19
LVH is found early in end-stage chronic renal disease, and
it is usually considered irreversible,32 though some recent
studies suggest it can regress in the long term.33,34 Juan-
García et al.35 ﬁnd a relationship between hydration status and
eccentric hypertrophy, but they do not consider sex in order to
ﬁx the threshold for hypertrophy. We did not demonstrate this
relationship. As previously commented, volume overload may
be decrease in our population, due to a relatively aggressive
monitoring of volume status: right cavities were not dilated,
pulmonary systolic pressure was very low (although its deter-
mination can be affected by dialysis), and pericardial effusion
was scarcely present. As them, our prevalence of hyperten-
sion is less than data reported in literature (30.3% instead
of about 60%) and there was no difference in distribution of
interdialyisis hypertension. Inferior vena cava (IVC) diameter
can be useful for estimating intravascular volume status36; we
found no difference in IVC diameter between our groups. Our
echocardiographic studies were performed in the day between
dialysis sessions in order to keep homogeneity. It is also impor-Please cite this article in press as: Cristina Di Gioia M, et al. Echocardiogr
hydration. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.06.003
tant to index diameter values to BSA or height in order to avoid
inaccuracies, as shown by the change in signiﬁcation when
not doing so in our population. Time on dialysis and age affect x x(x x):xxx–xxx
prevalence of hypertrophy, and the relatively small population
could affect to distribution of LVH between groups.
Conclusions
We found that left atrial volume index determined by echo-
cardiographic Area-length method, but not left ventricle
hypertrophy or dimensions of cavities, are related on hydra-
tion status based on bioimpedance measured time-averaged
ﬂuid overload, and does not related on FO/ECW.
Limitations
Although relatively unselected, our population represents a
single center and it is relatively small. People with previously
known cardiopathy or bad acoustic window were excluded. No
important valvulopathies were found, and systolic disfunction
or previous cardiomiopathy was also rare, although this could
favor homogeneity. Echocardiography measurements are sub-
ject to inaccuracies. Registries were reviewed by a single
echocardiographer, and the studies performed by an experi-
enced group into a hospital Echocardiography laboratory, but
interobserver variability could affect results. Although values
were adjusted for different variables in multivariate models,
confounding factors may persist. Prognostic studies are ongo-
ing. As in all observational studies, no conclusion regarding
causality can be drawn.
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